Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Journal of Translational Medicine|July 11, 2025
Recurrent waning of anti-SARS-CoV-2 neutralizing antibodies despite multiple antigen encountersEdwards Pradenas, Victor Urrea, Silvia Marfil, et al.
Journal of Virology|November 6, 2015
A Subset of CD4/CD8 Double-Negative T Cells Expresses HIV Proteins in Patients on Antiretroviral TherapyLaura K DeMaster, Xiaohe Liu, D Jake VanBelzen, et al.
Vaccine|April 19, 2024
VLPs generated by the fusion of RSV-F or hMPV-F glycoprotein to HIV-Gag show improved immunogenicity and neutralizing response in miceBenjamin Trinité, Eberhard Durr, Anna Pons-Grífols, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 11, 2020
PSGL-1 restricts HIV-1 infectivity by blocking virus particle attachment to target cellsYajing Fu, Sijia He, Abdul A Waheed, et al.
International Journal of Molecular Sciences|May 27, 2023
Exploring FeLV-Gag-Based VLPs as a New Vaccine Platform-Analysis of Production and ImmunogenicityRaquel Ortiz, Ana Barajas, Anna Pons-Grífols, et al.
Viruses|June 27, 2024
Production and Immunogenicity of FeLV Gag-Based VLPs Exposing a Stabilized FeLV Envelope GlycoproteinRaquel Ortiz, Ana Barajas, Anna Pons-Grífols, et al.
Science Advances|January 22, 2019
Cofilin hyperactivation in HIV infection and targeting the cofilin pathway using an anti-α4β7 integrin antibodySijia He, Yajing Fu, Jia Guo, et al.
Frontiers in Immunology|May 16, 2022
Virological and Clinical Determinants of the Magnitude of Humoral Responses to SARS-CoV-2 in Mild-Symptomatic IndividualsEdwards Pradenas, Maria Ubals, Víctor Urrea, et al.
Viruses|December 28, 2021
First Detection of SARS-CoV-2 Delta (B.1.617.2) Variant of Concern in a Dog with Clinical Signs in SpainLeira Fernández-Bastit, Jordi Rodon, Edwards Pradenas, et al.
Protein Science : a Publication of the Protein Society|January 28, 2026
Optimized ACE2-Fc fusion proteins with picomolar neutralization activity against highly evolved SARS-CoV-2 variantsFerran Abancó, Ferran Tarrés-Freixas, Rosalba Lepore, et al.
Pageof 6